Get started
REBUS HLDGS INC.REBUS HLDGS INC.REBUS HLDGS INC.

REBUS HLDGS INC.

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Seasonals

RBSH chart


Full chart

RBSH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
32.00 USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪32.13 M‬
Beta (1Y)
45.88

About REBUS HLDGS INC.


Sector
Health Technology
Industry
Biotechnology
CEO
Silvestre Raul
Website
inspyrtherapeutics.com
Headquarters
Westlake Village
Founded
2003
FIGI
BBG000PBSB93
Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RBSH is 0.000001 USD — it hasn't changed in the past 24 hours. Watch REBUS HLDGS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange REBUS HLDGS INC. stocks are traded under the ticker RBSH.
RBSH stock hasn't changed in a week, the last month showed zero change in price, over the last year REBUS HLDGS INC. has showed a −99.98% decrease.
RBSH reached its all-time high on Feb 13, 2019 with the price of 22,099.153577 USD, and its all-time low was 0.000001 USD and was reached on May 20, 2024. View more price dynamics on RBSH chart.
See other stocks reaching their highest and lowest prices.
RBSH stock is 0.00% volatile and has beta coefficient of 45.88. Track REBUS HLDGS INC. stock price on the chart and check out the list of the most volatile stocks — is REBUS HLDGS INC. there?
Yes, you can track REBUS HLDGS INC. financials in yearly and quarterly reports right on TradingView.
REBUS HLDGS INC. is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
No, RBSH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RBSH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REBUS HLDGS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REBUS HLDGS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REBUS HLDGS INC. stock shows the sell signal. See more of REBUS HLDGS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.